Cargando…

Concurrent use of palbociclib and radiation therapy: single-centre experience and review of the literature

Palbociclib in combination with endocrine therapy increases progression-free survival in patients with ER-positive, HER2-negative advanced breast cancer (BC). In this study, we retrospectively evaluated safety in the first patient treated with concurrent use of palbociclib and radiation therapy (RT)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beddok, Arnaud, Xu, Hao Ping, Henry, Alexandre Arsène, Porte, Baptiste, Fourquet, Alain, Cottu, Paul, Kirova, Youlia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493877/ https://www.ncbi.nlm.nih.gov/pubmed/32595213 http://dx.doi.org/10.1038/s41416-020-0957-9

Ejemplares similares

Combination of Modern Radiotherapy and New Targeted Treatments for Breast Cancer Management
por: Beddok, Arnaud, et al.
Publicado: (2021)

Assessment of Side Effects of Radiation Therapy in Patients With COVID-19 Treated for Early-Stage Breast Cancer
por: Allali, S., et al.
Publicado: (2021)

1586P Assessment of side effects of radiation therapy in patients with COVID-19 treated for early-stage breast cancer
por: Allali, S., et al.
Publicado: (2021)

Can we treat with radiation breast cancer patients with covid-19 infection? Results from a prospective study
por: Allali, S., et al.
Publicado: (2022)

Radiation Exposure of Cardiac Conduction Nodes During Breast Proton Therapy
por: Loap, Pierre, et al.
Publicado: (2023)

The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy—a single center experience
por: Arsene-Henry, Alexandre, et al.
Publicado: (2018)

Patterns of loco regional failure in women with breast cancer treated by Postmastectomy Conformal Electron Beam Radiation Therapy (PMERT): Large scale single center experience
por: Loganadane, Gokoulakrichenane, et al.
Publicado: (2017)

Neoadjuvant Concurrent Radiotherapy and Chemotherapy in Early Breast Cancer Patients: Long-Term Results of a Prospective Phase II Trial
por: Jornet, Diane, et al.
Publicado: (2021)

Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer
por: Porte, B., et al.
Publicado: (2020)

Tolerance and Oncological Outcomes of In-Field Reirradiation for Locally Recurrent Breast Cancer: A Long-Term Single-Center Experience
por: Baude, Jérémy, et al.
Publicado: (2023)

Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer
por: Cai, Gang, et al.
Publicado: (2019)

Radiodermatitis and Fibrosis in the Context of Breast Radiation Therapy: A Critical Review
por: Allali, Sofiane, et al.
Publicado: (2021)

Pertuzumab and Trastuzumab Combination with Concomitant Locoregional Radiotherapy for the Treatment of Breast Cancers with HER2 Receptor Overexpression
por: Aboudaram, Amélie, et al.
Publicado: (2021)

Radiotherapy in the Management of Non-Metastatic Inflammatory Breast Cancers: A Retrospective Observational Study
por: Nicaise, Benjamin, et al.
Publicado: (2021)

Pleural radiation-induced sarcoma: a SEER population-based description of a rare entity
por: Loap, Pierre, et al.
Publicado: (2021)

Cicaderma® in radiation–related dermatitis of breast cancer: Results from the multicentric randomised phase III CICA-RT
por: Racadot, Séverine, et al.
Publicado: (2023)

Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients?
por: Allali, S., et al.
Publicado: (2022)

Safety of palbociclib concurrent with palliative pelvic radiotherapy: discussion of a case of increased toxicity and brief review of literature
por: Dasgupta, Archya, et al.
Publicado: (2020)

Fast Neutron Therapy for Breast Cancer Treatment: An Effective Technique Sinking into Oblivion
por: Loap, Pierre, et al.
Publicado: (2020)

Helical Tomotherapy for Inoperable Breast Cancer: A New Promising Tool
por: Chira, Ciprian, et al.
Publicado: (2013)

Long-Term Prognostic Performance of Ki67 Rate in Early Stage, pT1-pT2, pN0, Invasive Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2013)

A Comprehensive Primer on Radiation Oncology for Non-Radiation Oncologists
por: Beddok, Arnaud, et al.
Publicado: (2023)

Technique alternatives for breast radiation oncology: Conventional radiation therapy to tomotherapy
por: Fournier-Bidoz, N., et al.
Publicado: (2009)

Do We Need to Delineate the Humeral Head in Breast Cancer Patients?
por: Belaidi, Lahcene, et al.
Publicado: (2022)

The effects of palbociclib in combination with radiation in preclinical models of aggressive meningioma
por: Horbinski, Craig, et al.
Publicado: (2021)

Two Novel Palbociclib-Resorcinol and Palbociclib-Orcinol Cocrystals with Enhanced Solubility and Dissolution Rate
por: Duan, Chenxin, et al.
Publicado: (2021)

Palbociclib-Induced Pneumonitis: A Case Report and Review of the Literature
por: Sarkisian, Saro, et al.
Publicado: (2020)

Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature
por: Carausu, Marcela, et al.
Publicado: (2019)

Treatment and outcome of a patient with radiation-induced organizing pneumonia in the context of coronavirus disease 2019 (COVID-19)
por: Beddok, Arnaud, et al.
Publicado: (2021)

Radiothérapie mammaire dans le contexte de la pandémie de COVID-19 : astuces pratiques en période épidémique et conseils pour la reprise de l’activité en fin de crise
por: Loap, P., et al.
Publicado: (2020)

Combination of palbociclib and radiotherapy for glioblastoma
por: Whittaker, Shane, et al.
Publicado: (2017)

Palbociclib-Induced Liver Failure
por: Atallah, Rami, et al.
Publicado: (2020)

A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes
por: Foy, Jean-Philippe, et al.
Publicado: (2017)

Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients
por: Darrigues, Lauren, et al.
Publicado: (2021)

Accounting for concurrent antihyperglycemic medication changes in dietary and physical activity interventions: A focused literature review
por: Campbell, Dennis B, et al.
Publicado: (2022)

Palbociclib in the treatment of recurrent ovarian cancer
por: Lee, Dai Wee, et al.
Publicado: (2020)

Palbociclib in breast cancer neoadjuvant setting
por: Duarte, Sílvia Alexandra Cabral, et al.
Publicado: (2021)

Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
por: Kim, Jee Hyun, et al.
Publicado: (2021)

Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation
por: Clément-Zhao, Alice, et al.
Publicado: (2019)

Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers
por: El-Botty, Rania, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4vk5bdg5s3ucjeurleompntl62